Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/34431
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Eskiler, Gamze Güney | - |
dc.date.accessioned | 2023-10-18T12:39:27Z | - |
dc.date.available | 2023-10-18T12:39:27Z | - |
dc.date.issued | 2018-10 | - |
dc.identifier.citation | Eryılmaz, I. E. vd. (2018). ''In vitro cytotoxic and antiproliferative effects of usnic acid on hormone-dependent breast and prostate cancer cells''. Journal of Biochemical and Molecular Toxicology, 32(10). | en_US |
dc.identifier.issn | 1095-6670 | - |
dc.identifier.issn | 1099-0461 | - |
dc.identifier.uri | https://doi.org/10.1002/jbt.22208 | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1002/jbt.22208 | - |
dc.identifier.uri | http://hdl.handle.net/11452/34431 | - |
dc.description.abstract | The aim of the current study was first to investigate cytotoxic activity of usnic acid (UA) on hormone-dependent breast and prostate cancer, and normal cells. Cells were treated with increasing concentrations (25 to 150 mu M) of UA for 48hours and cell viability, quantitative and morphological analysis of cell death, and cell cycle analysis were performed. UA was shown to have selective cytotoxicity on hormone-dependent cancer cells with the IC50 levels of 71.4 and 77.5 mu M for MCF7 and LNCaP cells, respectively. UA induced apoptotic cell death and G0/G1 cell cycle arrest without damaging normal cells. MCF7 cells were more sensitive to UA than LNCaP cells. Our results first revealed that UA is a promising candidate as an alternative agent for hormone-dependent breast and prostate cancers. However, molecular mechanism underlying the UA-mediated cell death in cancer cells should be investigated further. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Biochemistry & molecular biology | en_US |
dc.subject | Toxicology | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | Hormone-dependent cancers | en_US |
dc.subject | Prostate cancer | en_US |
dc.subject | Usnic acid | en_US |
dc.subject | Adjuvant tamoxifen | en_US |
dc.subject | L-methionine | en_US |
dc.subject | Dna-damage | en_US |
dc.subject | Therapy | en_US |
dc.subject | Receptors | en_US |
dc.subject | Lncap | en_US |
dc.subject | Mcf-7 | en_US |
dc.subject | Mechanisms | en_US |
dc.subject | Apoptosis | en_US |
dc.subject | Compound | en_US |
dc.subject.mesh | Antineoplastic agents | en_US |
dc.subject.mesh | Apoptosis | en_US |
dc.subject.mesh | Benzofurans | en_US |
dc.subject.mesh | Breast neoplasms | en_US |
dc.subject.mesh | Cell line | en_US |
dc.subject.mesh | Cell line, tumor | en_US |
dc.subject.mesh | Cell proliferation | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | G1 phase | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Inhibitory concentration 50 | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Neoplasms, hormone dependent | en_US |
dc.subject.mesh | Prostatic neoplasms | en_US |
dc.subject.mesh | Resting phase, cell cycle | en_US |
dc.title | In vitro cytotoxic and antiproliferative effects of usnic acid on hormone-dependent breast and prostate cancer cells | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000447551700009 | tr_TR |
dc.identifier.scopus | 2-s2.0-85052431648 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Biyoloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-3316-316X | tr_TR |
dc.contributor.orcid | 0000-0001-7904-883X | tr_TR |
dc.contributor.orcid | 0000-0002-1619-6680 | tr_TR |
dc.contributor.orcid | 0000-0002-3820-424X | tr_TR |
dc.identifier.volume | 32 | tr_TR |
dc.identifier.issue | 10 | tr_TR |
dc.relation.journal | Journal of Biochemical and Molecular Toxicology | en_US |
dc.contributor.buuauthor | Eryılmaz, Işıl Ezgi | - |
dc.contributor.buuauthor | Egeli, Ünal | - |
dc.contributor.buuauthor | Yurdacan, Beste | - |
dc.contributor.buuauthor | Çeçener, Gülşah | - |
dc.contributor.buuauthor | Tunca, Berrin | - |
dc.contributor.researcherid | GWV-3548-2022 | tr_TR |
dc.contributor.researcherid | AAH-1656-2021 | tr_TR |
dc.contributor.researcherid | AAH-1420-2021 | tr_TR |
dc.contributor.researcherid | ABI-6078-2020 | tr_TR |
dc.contributor.researcherid | AAP-9988-2020 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.identifier.pubmed | 30101414 | tr_TR |
dc.subject.wos | Biochemistry & molecular biology | en_US |
dc.subject.wos | Toxicology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 (Biochemistry & molecular biology) | en_US |
dc.wos.quartile | Q3 (Toxicology) | en_US |
dc.contributor.scopusid | 57189380840 | tr_TR |
dc.contributor.scopusid | 55665145000 | tr_TR |
dc.contributor.scopusid | 57203621058 | tr_TR |
dc.contributor.scopusid | 6508156530 | tr_TR |
dc.contributor.scopusid | 6602965754 | tr_TR |
dc.subject.scopus | Usnic Acid; Extract; Lichen (Disease) | en_US |
dc.subject.emtree | Hormone | en_US |
dc.subject.emtree | Usnic acid | en_US |
dc.subject.emtree | Antineoplastic agent | en_US |
dc.subject.emtree | Benzofuran derivative | en_US |
dc.subject.emtree | Usnic acid | en_US |
dc.subject.emtree | Antiproliferative activity | en_US |
dc.subject.emtree | Apoptosis | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Breast cancer | en_US |
dc.subject.emtree | Cancer cell | en_US |
dc.subject.emtree | Cell cycle regulation | en_US |
dc.subject.emtree | Cell proliferation | en_US |
dc.subject.emtree | Cell viability | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Cytotoxicity | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human cell | en_US |
dc.subject.emtree | IC50 | en_US |
dc.subject.emtree | In vitro study | en_US |
dc.subject.emtree | LNCaP cell line | en_US |
dc.subject.emtree | MCF-7 cell line | en_US |
dc.subject.emtree | Percentage of cells in G0/G1 phase | en_US |
dc.subject.emtree | Prostate cancer | en_US |
dc.subject.emtree | Breast tumor | en_US |
dc.subject.emtree | Cell cycle G0 phase | en_US |
dc.subject.emtree | Cell cycle G1 phase | en_US |
dc.subject.emtree | Cell line | en_US |
dc.subject.emtree | Drug effect | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Neoplasm | en_US |
dc.subject.emtree | Pathology | en_US |
dc.subject.emtree | Prostate tumor | en_US |
dc.subject.emtree | Tumor cell line | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.